pubmed-article:15802968 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15802968 | lifeskim:mentions | umls-concept:C0019196 | lld:lifeskim |
pubmed-article:15802968 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15802968 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
pubmed-article:15802968 | lifeskim:mentions | umls-concept:C0596988 | lld:lifeskim |
pubmed-article:15802968 | lifeskim:mentions | umls-concept:C0002085 | lld:lifeskim |
pubmed-article:15802968 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
pubmed-article:15802968 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:15802968 | pubmed:dateCreated | 2005-4-1 | lld:pubmed |
pubmed-article:15802968 | pubmed:abstractText | A 32-base pair deletion in the CC-chemokine receptor 5 gene (CCR5), associated with resistance to human immunodeficiency virus type 1 (HIV-1) infection, has recently been suggested to act as an adverse host factor in hepatitis C virus (HCV) infection. To examine this hypothesis, we determined the CCR5-Delta32 allele frequency by polymerase chain reaction in a Belgian cohort of 163 HCV-infected patients and 310 healthy control subjects. The resulting CCR5-Delta32 allele frequencies were 0.080 and 0.119 for the patient group and control group, respectively. In contrast with a previous study, we could not show a statistically significant difference between the CCR5-Delta32 allele frequencies in HCV patients and controls. Moreover, genotype distributions in both populations were in agreement with Hardy-Weinberg equilibrium. Our results do not support the hypothesis that the CCR5-Delta32 mutant allele is a risk factor for hepatitis C virus infection. | lld:pubmed |
pubmed-article:15802968 | pubmed:language | eng | lld:pubmed |
pubmed-article:15802968 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15802968 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15802968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15802968 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15802968 | pubmed:issn | 0882-8245 | lld:pubmed |
pubmed-article:15802968 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:15802968 | pubmed:author | pubmed-author:NevensFrederi... | lld:pubmed |
pubmed-article:15802968 | pubmed:author | pubmed-author:WollantsElkeE | lld:pubmed |
pubmed-article:15802968 | pubmed:author | pubmed-author:ThoelenIngeI | lld:pubmed |
pubmed-article:15802968 | pubmed:author | pubmed-author:BuntinxFrankF | lld:pubmed |
pubmed-article:15802968 | pubmed:author | pubmed-author:MaesPietP | lld:pubmed |
pubmed-article:15802968 | pubmed:author | pubmed-author:VerbeeckJanni... | lld:pubmed |
pubmed-article:15802968 | pubmed:author | pubmed-author:RobaeysGeertG | lld:pubmed |
pubmed-article:15802968 | pubmed:author | pubmed-author:MatheïCathyC | lld:pubmed |
pubmed-article:15802968 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15802968 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:15802968 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15802968 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15802968 | pubmed:pagination | 232-5 | lld:pubmed |
pubmed-article:15802968 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15802968 | pubmed:meshHeading | pubmed-meshheading:15802968... | lld:pubmed |
pubmed-article:15802968 | pubmed:meshHeading | pubmed-meshheading:15802968... | lld:pubmed |
pubmed-article:15802968 | pubmed:meshHeading | pubmed-meshheading:15802968... | lld:pubmed |
pubmed-article:15802968 | pubmed:meshHeading | pubmed-meshheading:15802968... | lld:pubmed |
pubmed-article:15802968 | pubmed:meshHeading | pubmed-meshheading:15802968... | lld:pubmed |
pubmed-article:15802968 | pubmed:meshHeading | pubmed-meshheading:15802968... | lld:pubmed |
pubmed-article:15802968 | pubmed:meshHeading | pubmed-meshheading:15802968... | lld:pubmed |
pubmed-article:15802968 | pubmed:meshHeading | pubmed-meshheading:15802968... | lld:pubmed |
pubmed-article:15802968 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15802968 | pubmed:articleTitle | Frequency of the CCR5-Delta32 mutant allele is not increased in Belgian hepatitis C virus-infected patients. | lld:pubmed |
pubmed-article:15802968 | pubmed:affiliation | Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, Rega Institute for Medical Research, University of Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium. | lld:pubmed |
pubmed-article:15802968 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15802968 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:1234 | entrezgene:pubmed | pubmed-article:15802968 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15802968 | lld:entrezgene |